Molecular Pathogenesis of Cardiac Failure due to Gene Abnormalities

基因异常导致心力衰竭的分子发病机制

基本信息

  • 批准号:
    13470142
  • 负责人:
  • 金额:
    $ 6.27万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2003
  • 项目状态:
    已结题

项目摘要

Idiopathic cardiomyopathy was defined as cardiomyopathy of unknown etiology. Recent molecular genetic analysis has revealed that gene abnormalities are involved in the etiology and/or pathogenesis of idiopathic cardiomyopathy. As well, hypertensive cardiomyopathy may also be relevant to the gene abnormalities in the pathogenesis. In this study, we have revealed that mutations in the genes for Z-disk elements, TTN, TCAP, MLP, and Cypher, cause cardiomyopathy. Functional studies of the mutations in each disease gene have shown that hypertrophic cardiomyopathy-related mutations increase the binding ability of the Z-disk elements, whereas dilated cardiomyopathy-related mutations decrease the binding ability. It also has been demonstrated that the Z-disk plays a key role in the stretch-sensing of cardiomyocytes from the analysis of a well known dilated cardiomyopathy model of MLP deficient mice. It was suggested that the stretch-response involved phosphorylation of Z-disk proteins, because the Z-disk protein abnormalities were predicted to change the distribution of calcineurin and PKC. In addition, Ca-sensitization and -desensitization played a crucial role in the pathogenesis of cardiac hypertrophy and failure, respectively. Analysis of hypertrophied and dilated hearts from M21-transgenic mice and Dah1 salt-sensitive hypertensive rats by DNA-chip technology showed that a number of genes were involved in the pathogenesis of cardiomyopathy. One of the new genes identified to be differentially expressed in the cardiac hypertrophy and failure is a growth factor-like gene specifically expressed in the heart. We identified a mutation in that growth factor-like gene that was associated with hypertensive cardiomyopathy.
特发性心肌病被定义为未知病因的心肌病。最近的分子遗传分析表明,基因异常与特发性心肌病的病因和/或发病机理有关。同样,高血压心肌病也可能与发病机理中的基因异常有关。在这项研究中,我们揭示了Z磁盘元素TTN,TCAP,MLP和Cypher的突变引起心肌病。每个疾病基因突变的功能研究表明,肥厚性心肌病相关的突变会增加Z磁盘元素的结合能力,而扩张的心肌病变相关的突变则降低了结合能力。还已经证明,Z磁盘在对MLP缺乏小鼠的众所周知的扩张心肌病模型的分析中通过分析心肌细胞的拉伸感应起关键作用。有人提出,拉伸响应涉及Z二烟蛋白的磷酸化,因为预计Z-二烟蛋白异常会改变钙调蛋白和PKC的分布。此外,CA-敏化和 - 敏化分别在心脏肥大和衰竭的发病机理中起着至关重要的作用。通过DNA-CHIP技术对M21-转基因小鼠和DAH1盐敏感大鼠的肥大和扩张心脏的分析表明,许多基因参与心肌病的发病机理。在心脏肥大中鉴定出差异表达的新基因之一,失败是一种特异性在心脏中表达的生长因子样基因。我们确定了与高血压心肌病有关的类似生长因子样基因的突变。

项目成果

期刊论文数量(64)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Knoll R, Hoshijima M, Hoffmann HM, Person V, Lorenzen-Schmidt I, Bang M-L, Hayashi T, Shiga N, Yasukawa H, Schaper W, McKenna W, Yokoyama M, Schork J, Jeffrey H, Omens J, Andrew D, McCulloch A, Kimura A, Gregorio CC, Poller W, Schaper J, Schultheless HP,
Knoll R、Hoshijima M、Hoffmann HM、Person V、Lorenzen-Schmidt I、Bang M-L、Hayashi T、Shiga N、Yasukawa H、Schaper W、McKenna W、Yokoyama M、Schork J、Jeffrey H、Omens J、Andrew D、
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
1toh-Satoh M, Hayashi T, Nishi H, et al.: "Titin mutations as the molecular basis for dilated cardiomyopathy"Biochem. Biophys. Res. Commun.. 291. 385-393 (2002)
1toh-Satoh M、Hayashi T、Nishi H 等人:“Titin 突变是扩张型心肌病的分子基础”Biochem。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kimura A, Itoh-Satoh M, Hayashi T, Takahashi M, Arimura T: "Molecular etiology of idiopathic cardiomyopathy in Asian populations."J Cardiol.. 37. S139-S146 (2002)
Kimura A、Itoh-Satoh M、Hayashi T、Takahashi M、Arimura T:“亚洲人群特发性心肌病的分子病因学”。J Cardiol.. 37. S139-S146 (2002)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ogimoto A, et al.: "17-year follow-up study of a patient with obstructive hypertrophic cardiomyopathy with a deletion mutation in the cardiac myosin binding protein C gene."Circ J.. 68. 174-177 (2004)
Ogimoto A 等人:“对一名患有心肌肌球蛋白结合蛋白 C 基因缺失突变的阻塞性肥厚型心肌病患者进行的 17 年随访研究。”Circ J.. 68. 174-177 (2004)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Arimura T, Suematsu N, Zhou YB, et al.: "Identification, characterization and functional analysis of heart-specific myosin light chain phoshatase small subunit"J. Biol. Chem.. 276. 6073-6082 (2001)
Arimura T,Suematsu N,Zhou YB,等:“心脏特异性肌球蛋白轻链磷酸酶小亚基的鉴定、表征和功能分析”J。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KIMURA Akinori其他文献

Diversity of <i>ULBP5</i> in Old-World monkeys (Cercopithecidae) and divergence of the <i>ULBP</i> gene family in primates
旧世界猴(猴科)中 <i>ULBP5</i> 的多样性和灵长类动物中 <i>ULBP</i> 基因家族的分歧

KIMURA Akinori的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KIMURA Akinori', 18)}}的其他基金

Molecular pathogenesis of heart failure and arrhythmia caused by gene abnormalities
基因异常引起心力衰竭和心律失常的分子发病机制
  • 批准号:
    16H05296
  • 财政年份:
    2016
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Strategy for regulation of cardiac functional defects due to the abnormality in molecular distribution caused by gene mutations
基因突变导致分子分布异常导致心脏功能缺陷的调控策略
  • 批准号:
    25670172
  • 财政年份:
    2013
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Molecular basis for cardiac muscle diseases caused by functional abnormalities of Z-disc
Z盘功能异常引起的心肌疾病的分子基础
  • 批准号:
    23659414
  • 财政年份:
    2011
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development of strategies for handling heart failure based on the molecular pathogenesis of cardiomyopathy
基于心肌病的分子发病机制制定治疗心力衰竭的策略
  • 批准号:
    22390157
  • 财政年份:
    2010
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A Parallel Point Generation Using Monte Carlo Methods for Point Based Visualization of Multiple Volume Data
使用蒙特卡罗方法生成并行点以实现多体数据的基于点的可视化
  • 批准号:
    20700096
  • 财政年份:
    2009
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Research Projects to Clarify the Molecular Pathogenesis and to Develop Therapeutic or Preventive Strategy for Cardiomyopathy
阐明心肌病分子发病机制并制定治疗或预防策略的研究项目
  • 批准号:
    19390208
  • 财政年份:
    2007
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Investigation of the molecular mechanisms of cardiac failure focusing on the Z-disc abnormalities
以Z盘异常为中心的心力衰竭分子机制研究
  • 批准号:
    16390219
  • 财政年份:
    2004
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Identification of Disease-associated Genes for Cardiovascular Diseases
心血管疾病相关基因的鉴定
  • 批准号:
    12204004
  • 财政年份:
    2000
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Regulation of ectopic expression of HLA class II genes.
HLA II 类基因异位表达的调节。
  • 批准号:
    01480192
  • 财政年份:
    1989
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似国自然基金

PRMT4通过甲基化修饰HIF-1α调控心肌能量代谢促进心肌肥厚及心力衰竭的机制研究
  • 批准号:
    82300429
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
α-KG改善NPY/HMGB1介导的交感神经-免疫炎症串扰防治心力衰竭及益气活血利水法的干预
  • 批准号:
    82374389
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
PIEZO1点突变诱导心肌细胞铁死亡在心力衰竭中的作用及机制研究
  • 批准号:
    82302463
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于KDM5C-H3K4me2/3-HK2通路调控巨噬细胞糖酵解-炎症反应探讨益气活血利水法防治心力衰竭的作用机制
  • 批准号:
    82305114
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
MLIP调控AP-1稳定性促进缺血性心力衰竭合并骨骼肌萎缩的机制研究
  • 批准号:
    82370382
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目

相似海外基金

Examining the Function of a Novel Protein in the Cardiac Junctional Membrane Complex
检查心脏连接膜复合体中新型蛋白质的功能
  • 批准号:
    10749672
  • 财政年份:
    2024
  • 资助金额:
    $ 6.27万
  • 项目类别:
Aging of cardiac fibroblasts and heart failure: novel heart failure treatment through regeneration and transplantation of cardiac fibroblasts
心脏成纤维细胞的衰老和心力衰竭:通过心脏成纤维细胞的再生和移植治疗心力衰竭
  • 批准号:
    23K07526
  • 财政年份:
    2023
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The role of BET proteins in pathological cardiac remodeling
BET蛋白在病理性心脏重塑中的作用
  • 批准号:
    10538142
  • 财政年份:
    2023
  • 资助金额:
    $ 6.27万
  • 项目类别:
Nanowired humam cardiac organoid derived exosomes for heart repair
纳米线人类心脏类器官衍生的外泌体用于心脏修复
  • 批准号:
    10639040
  • 财政年份:
    2023
  • 资助金额:
    $ 6.27万
  • 项目类别:
REVAMP-PH: REpurposing Valsartan May Protect against Pulmonary Hypertension
REVAMP-PH:重新利用缬沙坦可以预防肺动脉高压
  • 批准号:
    10642368
  • 财政年份:
    2023
  • 资助金额:
    $ 6.27万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了